Lp-PLA2 Activity
| Alternate Names | Lipoprotein-Associated Phospholipase A2 Activity (LpPLA2), PLAC, PLAC Activity, Platelet Activating Factor Acetylhydrolase |
| Ordering Recommendation | Measurement of Lp-PLA2 may be used along with traditional cardiovascular risk factor measures for identifying individuals at higher risk of cardiovascular disease events. Clinical management may include beginning or intensifying risk reduction strategies. |
| Specimen | Lithium Heparin Plasma |
| Container Type | Green Top Tube
|
| Methodology | Enzyme Colormetric |
| Reference Range | Reduced Risk: <225 nmol/min/mL Increased Risk: ≥225 nmol/min/mL |
| Stability | 14 days |
| Transport Temp | Refrigerate 2°-8° C |
| Instructions | None |
| Days Performed | Daily |
| Report Available | 1-2 days |
| NY State Available | Yes |
| LOINC Code | 86951-1 |
| CPT Code | 83698 |
